Reposted by DocGlitz
In an interim analysis of a clinical trial, atacicept, a fusion protein that binds and inhibits two cytokines thought to be central to the pathophysiology of IgA nephropathy, significantly reduced proteinuria. Full ORIGIN 3 trial results and Research Summary: nej.md/3JEq8QL
#MedSky